Expertise

David brings 34 years of pharmaceutical, biotechnology, device, and diagnostic industry leadership experience in commercialization, market access, reimbursement, HEOR, government affairs, sales, and marketing. Currently, David co-leads the EVERSANA U.S. Pricing and Market Access practice and leads the EVERSANA MANAGEMENT CONSULTING practice in the EU and UK as well.​

David has an extensive background in life sciences management consulting focused on the disciplines of market access, pricing, payer and purchaser contracting, value dossier creation, channel and distribution, coding and reimbursement, and public policy supporting rare disease, oncology, radiopharmaceuticals, cell and gene, immunology, controlled substances, and general medicine​

Prior to joining EVERSANA, David spent 3 years in market access, reimbursement, and HEOR consulting leadership with Syneos Health LLC and Biotech Health Strategies, LLC. Throughout his career, David has helped build and lead multiple startup organizations in the US and ex-US with organizations such as Janssen Biotech, formerly Centocor, Inc., Braeburn Pharmaceuticals, Orexo US/AB, Indivior, Immunex Corporation, and Sanofi, formerly Marion Labs. For the past 27 years, David has led the access, pricing, reimbursement, channel, and government affairs efforts for each of the commercial organizations he served.​

David co-led the development of the reimbursement methodology for biologic medicines as part of the 2003 Medicare Modernization Act and supported the development of the essential health benefits as part of the 2010 Affordable Care Act.​

David holds a BS in Public Administration from Indiana University, O’Neill School of Public and Environmental Affairs.​

​